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Marko Bertog1
Prostaglandin E2 (PGE2) is the most abundant prostanoid in the kidney, affecting a wide range of renal functions. Conflicting
data have been reported regarding the effects of PGE2 on tubular water and ion transport. The amiloride-sensitive epithelial
sodium channel (ENaC) is rate limiting for transepithelial sodium transport in the aldosterone-sensitive distal nephron. The
aim of the present study was to explore a potential role of PGE2 in regulating ENaC in cortical collecting duct (CCD) cells.
Short-circuit current (ISC) measurements were performed using the murine mCCDcl1 cell line known to express characteristic
properties of CCD principal cells and to be responsive to physiological concentrations of aldosterone and vasopressin. PGE2
stimulated amiloride-sensitive ISC via basolateral prostaglandin E receptors type 4 (EP4) with an EC50 of ∼7.1 nM. The rapid
stimulatory effect of PGE2 on ISC resembled that of vasopressin. A maximum response was reached within minutes, coinciding
with an increased abundance of β-ENaC at the apical plasma membrane and elevated cytosolic cAMP levels. The effects of
PGE2 and vasopressin were nonadditive, indicating similar signaling cascades. Exposing mCCDcl1 cells to aldosterone caused a
much slower (∼2 h) increase of the amiloride-sensitive ISC. Interestingly, the rapid effect of PGE2 was preserved even after
aldosterone stimulation. Furthermore, application of arachidonic acid also increased the amiloride-sensitive ISC involving
basolateral EP4 receptors. Exposure to arachidonic acid resulted in elevated PGE2 in the basolateral medium in a
cyclooxygenase 1 (COX-1)–dependent manner. These data suggest that in the cortical collecting duct, locally produced and
secreted PGE2 can stimulate ENaC-mediated transepithelial sodium transport.
Introduction
In the kidney the amiloride-sensitive epithelial sodium channel
(ENaC) is localized to the apical membrane of tubular epithelial cells
lining the so-called aldosterone-sensitive distal nephron (ASDN).
This comprises the late distal convoluted tubule, the connecting
tubule, and the collecting duct (CD). In the ASDN, transepithelial
sodium transport critically depends on the activity and abundance of
ENaC. The precise regulation of ENaC is essential for the fine-tuning
of urinary sodium excretion to match dietary sodium intake. Thus,
ENaC regulation plays a key role for total body sodiumbalance and is
critical for the long-term control of extracellular fluid volume and
arterial blood pressure. ENaC is regulated by several hormones, in-
cluding aldosterone and vasopressin, as well as by several local
factors (Garty and Palmer, 1997; Loffing and Korbmacher, 2009;
Bankir et al., 2010; Rossier, 2014; Kleyman et al., 2018).
Prostanoids are derivatives of arachidonic acid and are pro-
duced and secreted by many different cells. Prostanoids have
complex effects on renal function (Grantham and Orloff, 1968;
Breyer and Breyer, 2000b) and contribute to the regulation of
sodium and water excretion, renin secretion, renal blood flow,
and glomerular filtration (Hao and Breyer, 2007). Because they
are rapidly metabolized, these derivatives are thought to act
within close proximity to the site of their synthesis in either an
autocrine or paracrine manner (Fenton and Knepper, 2007).
Prostaglandin E2 (PGE2), derived via cyclooxygenase (COX), is
the most abundant prostanoid in the kidney. There are con-
flicting reports regarding the effects of PGE2 on sodium and
water transport within the collecting duct (Breyer and Breyer
2000a). Several studies suggest that in the renal medulla, PGE2
reduces sodium absorption (Stokes and Kokko, 1977; Iino and
Imai, 1978). In contrast, inhibition of prostaglandin synthesis
has been reported to be associated with increased urinary so-
dium excretion in conscious dogs, probably due to diminished
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sodium reabsorption in the collecting duct (Kirschenbaum and
Stein, 1976). Moreover, PGE2 may be able to stimulate water and
sodium absorption within the cortical CD (CCD) to maintain blood
pressure in volume-contracted states (Hao and Breyer, 2008).
PGE2 exerts its diverse effects by binding to four distinct G
protein–coupled receptors: EP1–EP4 (Hao and Breyer, 2007). The
expression pattern of these receptors determines local effects of
PGE2 (Breyer and Breyer, 2000b). EP2 and EP4 receptors are Gαs-
coupled receptors, and ligand binding to these receptors stimulates
adenylyl cyclase (AC), raising cytosolic cAMP concentration. In
addition, alternative EP4 receptor pathways may play a role in
mediating downstream effects (Fujino and Regan, 2006; Li et al.,
2017). EP3 receptor is coupled to Gαi/o and has an inhibitory effect
on AC, thereby lowering cytosolic cAMP concentration. The EP1
receptor is Gαq/11 coupled and promotes signaling via inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol resulting in elevated intra-
cellular Ca2+ concentration and activation of protein kinase C (PKC;
Narumiya et al., 1999; Breyer and Breyer, 2001).
Findings in animal models of nephrogenic diabetes insipidus
indicate a likely role of prostaglandins in regulating renal water
transport. In these animals EP2 and EP4 receptor activation allevi-
ated urine-concentrating defects (Li et al., 2009; Olesen et al., 2011).
Conversely, nephron-specific or collecting duct-specific knockout of
EP4 receptor in mice promoted urine-concentrating defects (Gao
et al., 2015). Interestingly, in in vitro studies of the collecting
duct activation of EP2 and EP4 receptors promoted apical tar-
geting and phosphorylation of aquaporin-2 water channels,
reminiscent of the effect of vasopressin (Olesen et al., 2011,
2016; Gao et al., 2015). Vasopressin-dependent coupling between
amiloride-sensitive sodium transport and water flow has been
demonstrated in a mouse CCD cell line (mCCDcl1; Gaeggeler et al.,
2011) as well as in isolated perfused rat CCDs (Reif et al., 1986).
Presently, it is not known whether a potential modulatory effect
of PGE2 on tubular water transport is associated with an effect of
PGE2 on ENaC-mediated sodium absorption in the CCD.
The aim of the present study was to investigate whether PGE2
modifies ENaC-mediated transepithelial sodium transport in
mCCDcl1 cells. This cell line provides a highly differentiated and
hormone-responsive model of CCD principal cells (Gaeggeler
et al., 2005, 2011). It is well suited to study the regulation of
electrogenic transepithelial ion transport by hormonal and local
mediators (Edinger et al., 2014; Mansley et al., 2015, 2018, 2019).
We sought to identify the prostaglandin receptors present in this
model and explored the interplay between PGE2 and two key
hormones that promote salt and water reabsorption in the CCD,
namely aldosterone and vasopressin. Finally, we investigated
whether PGE2 is synthesized and secreted by mCCDcl1 cells.
Materials and methods
Cell culture
Mouse CCD cells (mCCDcl1) were kindly provided by Bernard
Rossier (University of Lausanne, Lausanne, Switzerland) and
cultured as described previously (Gaeggeler et al., 2005;
Mansley et al., 2015, 2018). Cells were routinely passaged every
7 d (passage 25–34) and maintained in cell culture dishes at 37°C
in a 5% CO2 atmosphere in Dulbecco’s modified Eagle’s Medium
(DMEM)/Ham’s F12 (1:1 vol/vol) medium supplemented with 2%
FBS, 1 nM triiodothyronine, 60 nM sodium selenite, 10 ng·ml−1
epidermal growth factor, 5 µg·ml−1 human apotransferrin, 50
nM dexamethasone, 5 µg·ml−1 insulin, 100 U·ml−1 penicillin, and
100 µg·ml−1 streptomycin. For experimental procedures, cells
were seeded onto Millicell-PCF culture plate inserts (EMD Mil-
lipore) with a membrane pore size of 0.4 µm and an effective
surface area of either 0.6 cm2 or 4.2 cm2 and grown to form a
polarized epithelial monolayer. At day 5 after seeding, the cell
culture medium was replaced by a medium devoid of FBS,
apotransferrin, and epidermal growth factor. Finally, 24 h before
experiments, dexamethasone was removed from the medium.
Chemicals and solutions
DMEM/Ham’s F12 (1:1 vol/vol) without phenol red was from
Life Technologies and FBS from PAA and Bio&Sell. SC-560,
AH23848, AH6809, GW627368X, and Sulprostone were from
Cayman Chemical (Biozol); PGE2 and indomethacin were from
Enzo Life Sciences. TCS2510 was from Tocris. Lumiracoxib was
kindly provided by Prof. Dr. K. Brune (Institute of Experimental
and Clinical Pharmacology and Toxicology, Friedrich-Alexander
University, Erlangen, Germany). All other drugs were ordered
from Sigma-Aldrich.
Transepithelial measurements
Experimental procedures were essentially the same as described
previously (Bertog et al., 2008; Mansley et al., 2015, 2018).
Briefly, transepithelial voltage (Vte) and resistance (Rte) were
routinely checked using a commercially available epithelial volt-
ohm meter and a set of two sticks “STX” electrodes (World
Precision Instruments). On days 9–11, inserts with confluent
mCCDcl1 cell monolayers were transferred to Ussing chambers
for continuous equivalent short-circuit current (ISC) measure-
ments using a CVC6 clamp device (Fiebig) as described previ-
ously (Bertog et al., 1999). Alternatively, modified Ussing
chambers were used and kept in an incubator gassed with 5%
CO2, and the temperature was maintained at 37°C (Mansley
et al., 2015, 2018). These miniaturized chambers were de-
signed to minimize mechanical perturbations and to reduce the
bath volumes in the apical and basolateral compartment to
0.35–0.6 ml and 0.55–1.0 ml, respectively. Both experimental
approaches showed similar results in the transepithelial pa-
rameters investigated. Rte was evaluated every 2–30 s by mea-
suring voltage deflections induced by 400-ms symmetrical
square current pulses of ± 3–5 µA. Using Rte and open-circuit Vte,
the equivalent ISC was calculated according to Ohm’s law. Con-
ventionally, a lumen-negative Vte corresponds to a positive ISC
whichmay be due to electrogenic cation absorption, electrogenic
anion secretion or a combination of both. After transfer into
Ussing chambers, cells were allowed to equilibrate for 30 to
60 min before manipulations took place. At the end of each
experiment, amiloride (10 µM) was applied to the apical com-
partment to determine the ENaC-mediated ISC component.
Reverse transcription (RT) PCR
Total RNAwas extracted frommCCDcl1 cells following transepithelial
measurements using NucleoSpin RNA Kit-XS (Macherey-Nagel)
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according to the manufacturer’s instructions. Lysates from two 0.6-
cm2 cell culture plate inserts were pooled to enhance the RNA
concentration.
For prostanoid receptors (EP1–EP4), RT and PCR amplification
were performed using an RNAReverse Transcription System Kit
(Promega). Specific primers (Table 1) for murine EP1–EP4 re-
ceptors and β-actin were designed as described previously
(Arakawa et al., 1996) and synthesized by Invitrogen. PCR cy-
cling conditions were 95°C for 2 min, followed by 32 repeats of
95°C for 30 s, 60°C for 45 s, and 72°C for 1 min. Final extension
time was 4 min at 72°C.
For all other primers, RT was performed with 0.5 µg RNA
using QuantiTect Reverse Transcription Kit (Qiagen) as per the
manufacturer’s protocol. Specific primers for the COX iso-
enzymes 1 and 2 (COX-1 and COX-2) and for the cytosolic PGE2
synthase (cPGES) were designed using universal probe library
system (Roche), whereas specific primers for the microsomal
PGE synthases-1 and -2 (mPGES1 and, mPGES2) were designed
as described previously (mPGES1: Soodvilai et al., 2009;
mPGES2: Yang et al., 2006a). Primers were obtained from
biomers.net. PCR was performed using 10 pM specific primers
in PCR buffer (buffer Y; Peqlab). Samples were denatured for
5 min at 95°C, followed by 35 repeats of 94°C for 1 min, 60°C for
1 min, and 72°C for 1 min. Final extension time was 10 min at
72°C. All reactions were performed in a MJ-Research PTC-200
Peltier Thermo Cycler (Biozym). Amplified PCR products were
separated by agarose gel electrophoresis (1.5% universal aga-
rose; Bio&Sell) and stained by ethidium bromide. Bands of PCR
products were extracted and sequenced (LGC Genomics). For
sequence comparison we used the standard nucleotide BLAST
software (National Center for Biotechnology Information, Na-
tional Library of Medicine).
Biotinylation assay and Western blotting
To detect β-ENaC in Western blot experiments, a previously
described custom-made antibody was used in a 1:2,000 dilution
(Krueger et al., 2009; Nesterov et al., 2016; Mansley et al., 2018).
Horseradish peroxidase–coupled goat anti-rabbit antibodies
were obtained from Santa Cruz Biotech and used in a dilution of
1:50,000.
Cell surface proteins were labeled using a biotinylation pro-
tocol similar to that previously described for surface bio-
tinylation of lung epithelial cell monolayers (Woollhead and
Baines, 2006). For biotinylation experiments, mCCDcl1 cells
were grown on permeable supports (Millicell-PCF inserts,
membrane size 4.2 cm2; EMD Millipore) for 10 d. All bio-
tinylation steps were performed at 4°C. Cells were chilled to 4°C
by washing three times with ice-cold PBS containing 0.7 mM
MgCl2 and 0.5 mM CaCl2 (PBS-CM). Cells were kept on ice, and
biotinylation of the apical cell surface was achieved by adding
borate buffer containing 85 mM NaCl, 5 mM KCl, and 15 mM
Na2B4O7, pH 9.0, containing 0.5 mg·ml−1 EZ-link sulfo-NHS-SS-
Biotin (Pierce). The basolateral compartment was exposed to
PBS-CM + 10% FBS. Cells were kept on ice and rocked for
30 min. Cells were washed once with PBS-CM and then the
reaction quenched by exposing both the apical and basolateral
surface of cells to PBS-CM + 10% FBS for a further 30 min. Cells
were washed twice with PBS-CM and then scraped into 200 µl
lysis buffer (0.4% deoxycholic acid, 1% Triton X-100, 50 mM
EGTA, and 10 mM Tris, pH 7.4) including a protease inhibitor
cocktail (Roche). A small sample was taken to determine protein
content by BCA assay. Biotinylated proteins were captured by
exposing the sample to 50 µl ImmunoPure immobilized Neu-
travidin agarose beads (Pierce), which had been washed twice
with PBS-CM and subsequently with lysis buffer. 250 µg sample
was added to the washed beads, and tubes were incubated on a
rotor overnight at 4°C. Samples were centrifuged for 2 min at
8,000 rpm (6,200 ×g) at 4°C, and the supernatant was collected
separately for the detection of intracellular proteins. Neu-
travidin beads were washed and centrifuged four times and the
biotinylated fraction was finally resuspended in 45 µl of 2× re-
ducing SDS-PAGE sample buffer (Rotiload 1; Roth).
All protein samples were heated for 5 min at 95°C before
loading on SDS gels. Proteins were separated by 10% SDS-PAGE,
transferred to polyvinylidene diflouride membranes by semidry
electroblotting, and probed with the indicated antibodies. Chemi-
luminescent signals were detected using Super Signal West Femto
Chemiluminescent Substrate (Pierce).
Measurement of PGE2 and cAMP concentrations
For PGE2 measurements, an enzyme immunoassay was used
according to the manufacturer’s protocol (Prostaglandin E2 Ex-
press EIA Kit—Monoclonal; Cayman Chemical Company). PGE2
concentrations were determined in diluted basolateral cell cul-
ture medium after incubating mCCDcl1 cells with arachidonic
acid, COX inhibitors, or vehicle at 37°C for 10 min.
For cAMP measurements, mCCDcl1 cells were lysed to release
intracellular cAMP, which was quantified using an enzyme
immunoassay according to the manufacturer’s instructions
(cAMP Biotrak competitive enzyme immunoassay system; GE
Healthcare). Cytosolic cAMP concentrations were determined in
cells exposed to PGE2 or vehicle at 37°C for 10 min. Protein
concentrations were determined with a bicinchoninic acid assay
(BCA Protein Assay Kit; Thermo Scientific).
Table 1. Primer pairs of target genes used for RT-PCR in this study
cDNA Sense primer (59→39) Antisense primer (59→39)
EP1 CGCAGGGTTCACGCACACGA CACTGTGCCGGGAACTACGC
EP2 AGGACTTCGATGGCAGAGGAG
AC
CAGCCCCTTACACTTCTCCAATG
EP3 CCGGGCACGTGGTGCTTCAT TAGCAGCAGATAAACCCAGG
EP4 TTCCGCTCGTGGTGCGAGTGT
TC
GAGGTGGTGTCTGCTTGGGTCAG
COX-1 CCTCTTTCCAGGAGCTCACA CGGGTAGAACTCTAAAGCATCG
COX-2 GGGAGTCTGGAACATTGTGAA GCACATTGTAAGTAGGTGGAC
TGT
mPGES1 AGCACACTGCTGGTCATCAA CTCCACATCTGGGTCACTCC
mPGES2 GACCCTGTACCAGTACAAGAC GAGGAGTCATTGAGCTGTTGC
cPGES CGAATTTTGACCGTTTCTCTG TGAATCATCATCTGCTCCATCT
β-Actin TCACCCACACTGTGCCCATCT
AC
GAGTACTTGCGCTCAGGAGGAGC
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All samples were measured as duplicates.
Data analysis
Data were analyzed using PRISM 5.04 for Windows (GraphPad
Software). Summarized data are presented as mean values ± SE
(SEM). Multiple comparisons were subjected to one-way ANOVA
followed by ad hoc post-tests as specified in the figure legends;
otherwise, Student’s t tests were used. P values < 0.05 were re-
quired to reject the null hypothesis; *, **, and *** represent P
values < 0.05, 0.01, and 0.001, respectively, and “ns” represents P
values ≥ 0.05. Numbers in parentheses in the figures signify the
number of samples studied.
Results
Basolateral application of PGE2 stimulates ENaC-mediated
transepithelial sodium transport in mCCDcl1 cells
Basolateral application of 100 nM PGE2 caused a sustained in-
crease of ISC (Fig. 1 A), which rose from a baseline value of 6.7 ±
0.7 μA·cm−2 to a maximal value of 23.7 ± 2.1 μA·cm−2 (n = 6, P <
0.001) within 5–10 min. This ISC increase of 17.0 ± 1.3 μA·cm−2
was associated with a decrease in Rte from 6.49 ± 0.41 to 2.61 ±
0.18 kΩ·cm2 (P < 0.001). In contrast, in matched vehicle-treated
control cells ISC and Rte remained stable (6.3 ± 0.9 μA·cm−2 and
6.40 ± 0.54 kΩ·cm2 versus 6.4 ± 0.9 μA·cm−2 and 6.34 ± 0.54
kΩ·cm2; n = 6). Importantly, apical application of PGE2 in a
concentration of up to 1 µMhad negligible effects on ISC (Fig. 1 A).
This indicates that the stimulatory effect of PGE2 ismediated by a
basolateral receptor. Apical application of amiloride (10 µM) at
the end of the experiments almost completely inhibited baseline
ISC in vehicle-treated cells and the stimulated ISC in PGE2-treated
cells. The inhibitory effect of amiloride on ISC was accompanied
by a 1.7-fold Rte increase in vehicle-treated cells (from 6.34 ± 0.54
kΩ·cm2 to 10.56 ± 0.45 kΩ·cm2, n = 6; P < 0.001) and a 2.6-fold Rte
increase in PGE2-treated cells (from 2.61 ± 0.18 kΩ·cm2 to 6.69 ±
0.18 kΩ·cm2, n = 6; P < 0.001). Thus, the stimulatory effect of
basolateral PGE2 on ISC can be attributed to an increase in ENaC-
mediated transepithelial sodium transport most likely due to an
activation of ENaC activity. The latter conclusion is supported by
the associated decrease in Rte most likely reflecting an increased
sodium conductance of the apical cell membrane. As illustrated
in Fig. 1 B, the stimulatory effect of basolateral PGE2 was con-
centration dependent, with a half-maximal effective concentra-
tion (EC50) of ∼7.1 nM. Furthermore, the PGE2-induced increase
in ISC was prevented when apical application of amiloride pre-
ceded addition of PGE2 (Fig. 1 C), which confirms that the
stimulatory effect of PGE2 is dependent on ENaC function. In-
terestingly, a small and transient ISC peak response to PGE2 was
consistently observed in the presence of amiloride (Fig. 1 C, left
panel; and Fig. 1 D, left panel). It was not an experimental arti-
fact, because it was not observed in vehicle-treated controls. This
amiloride-insensitive ISC component is most likely due to a
transient chloride secretory response mediated by Ca2+-
Figure 1. Basolateral PGE2 stimulates amiloride-sensitive ISC in mCCDcl1
cells. (A–C) Representative traces of continuous ISC recordings from mCCDcl1
cells are shown in the left panels and data from similar experiments are
summarized in the corresponding right panels. During the time periods in-
dicated by the open horizontal bar, PGE2 or vehicle (veh) was present. Apical
application of 10 µM amiloride (Ami) is indicated by a black horizontal bar.
(A) ISC recordings with basolateral PGE2 (bl; 100 nM), apical PGE2 (ap; 1 µM)
or vehicle (control) are represented by a black, gray, or dashed line, re-
spectively. (B) ISC recordings are shown with basolateral application of PGE2
(black lines) in concentrations from 0.1–100 nM or with vehicle (dashed line).
A nonlinear fit for the ISC response upon PGE2 application in concentrations of
10 pM to 10 µM was used to estimate EC50. (C) Basolateral PGE2 (100 nM)
was applied in the absence (control; dashed line) or presence of 10 µM
amiloride (black line). Arrow indicates time point of apical addition of amil-
oride or vehicle (control). In the control PGE2 recording, apical amiloride (10
µM) was added at the end of the experiment. To summarize data from dif-
ferent experiments as ΔISC values, the individual ISC values were corrected by
subtracting the corresponding baseline ISC value. Gray circles highlight the
initial phases of the ISC responses to PGE2. Summary data (right panels) are
presented as individual data points and/or mean values ± SEM. Numbers of
experiments are given in parenthesis. Statistical analysis was determined
using one-way ANOVA with Tukey’s multiple comparison test or Student’s
t test where appropriate; ***, P < 0.001. (D) The initial phases of the re-
sponses to basolateral PGE2 encircled in C are shown enlarged using
expanded scales. Arrows indicate the time point of PGE2 application in the
continuous presence (black bar, left panel) or absence (right panel) of amiloride.
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activated chloride channels (Sandrasagra et al., 2004; Mansley
et al., 2015). A close inspection of the initial phase of the ISC
response to PGE2 revealed that a similar initial ISC peak was
also detectable in the absence of amiloride (Fig. 1 D, right
panel). However, this ISC peak response was highly variable
and in most recordings was at least partially concealed by the
overlapping rapid onset of the much larger stimulatory effect
of PGE2 on the amiloride-sensitive ENaC-mediated ISC.
Therefore, it was not feasible to study this peak response
systematically. Taken together, these data indicate that in
mCCDcl1 cells basolateral PGE2 predominantly stimulates
ENaC-mediated transepithelial sodium transport most likely
by increasing apical ENaC activity.
PGE2 increases the abundance of β-ENaC at the
plasma membrane
An increase in the activity of ENaC can be caused by increasing
the open probability of the channel (PO), by increasing the
number of channels at the cell surface (N), or by a combination
of both factors. Using a biotinylation assay and Western blot
analysis with antibodies directed against mouse β-ENaC, an
increase (∼2.5 times) of β-ENaC protein was detected at the
apical surface of cells treated with 100 nM PGE2 on the baso-
lateral side compared with vehicle-treated cells (Fig. 2, A and B).
In the corresponding cytosolic fractions, a difference in the
abundance of β-ENaC was not detected (data not shown). These
data indicate that the stimulatory effect of PGE2 on ENaC can be
attributed at least in part to an increased channel expression at
the apical plasma membrane of mCCDcl1 cells.
PGE2 mediates its effects via basolateral EP4 receptors
To identify the prostanoid receptor responsible for the stimula-
tory effect of PGE2 on ENaC activity in mCCDcl1 cells, a pharma-
cological approach with known receptor agonists and antagonists
was used. Basolateral addition of an EP2 receptor antagonist
(AH6809; 10 µM), which also shows some affinity to murine EP1
receptor (Kiriyama et al., 1997), or of sulprostone (100 nM), an
agonist of EP1 and EP3 receptors, had no effect on baseline ISC and
did not alter the stimulatory response to PGE2 (Fig. 3). In contrast,
the EP4 receptor antagonists AH23848 (100 µM) or GW627368X (2
µM) largely diminished or nearly abolished the PGE2-mediated
stimulatory response, respectively (Fig. 4 A). The small transient
peak response to PGE2 appeared to be preserved in the presence of
the EP4 receptor antagonist GW627368X (Fig. 4 A, middle panel).
Basolateral application of TCS2510 (100 nM), an EP4 receptor
agonist, stimulated the amiloride-sensitive current in a similar
manner as PGE2 (Fig. 4 B). These data indicate that PGE2 stim-
ulates ENaC activity via a basolateral Gαs-coupled EP4 receptor in
mCCDcl1 cells.
The stimulatory effect of PGE2 on ENaC is similar to that of
vasopressin and forskolin and is associated with an increase in
intracellular cAMP
It has previously been reported that in mCCDcl1 cells, ENaC-
mediated transepithelial sodium transport can be stimulated
by vasopressin via a basolateral V2 receptor (Gaeggeler et al.,
2011). Therefore, experiments were performed to compare the
Figure 2. PGE2 elevates the abundance of β-ENaC at the cell surface.
(A) β-ENaC was detected by Western blot analysis using biotinylated cell
surface proteins isolated from mCCDcl1 cells exposed on the basolateral side
for 30 min to 100 nM PGE2 (+) or vehicle (−). The four blots represent data
from four individual experiments using two filters of mCCDcl1 cells per ex-
perimental group. Arrowheads to the right of the blots indicate band sizes of
∼110 kD (filled) and ∼105 kD (open) as expected for glycosylated and non-
gylcosylated β-ENaC. (B) The blots shown in A were analyzed by densi-
tometry, and the signals of the lower and upper bands of each lane were
combined (105 + 110 kD). In each experiment, two matched mCCDcl1 samples
were used per group (± PGE2) and an average value was determined for each
group. For each experiment, the average value from the PGE2-treated cells
was normalized to the average value of the nontreated cells (corresponding
values are connected by a dashed line). The mean ± SEM value represents the
average change in protein abundance compared with vehicle treatment.
Statistical analysis was performed using Student’s t test; *, P < 0.05 versus
solvent vehicle controls.
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effect of vasopressin with that of PGE2 and to investigate a
possible interdependence of these effects. First, the stimulatory
effect of vasopressin was confirmed (Fig. 5, A and B). Basolateral
application of 25 pM vasopressin increased ISC to a similar
extent as 100 nM basolateral PGE2 in matched experiments.
Interestingly, exposure to PGE2 after prestimulation with va-
sopressin had no additional stimulatory effect on ISC (Fig. 5 A).
Similarly, when cells were initially exposed to PGE2, subsequent
application of vasopressin failed to stimulate ISC further (Fig. 5
B). These findings suggest that the effects of PGE2 and vaso-
pressin involve the same signaling pathway, i.e., cAMP/PKA. To
confirm this, further experiments were performed with
forskolin, a known activator of AC. Forskolin (10 µM) in-
creased ISC in a similar manner as vasopressin and PGE2 (Fig. 5
C). After exposure to forskolin, application of PGE2 (100 nM)
had no additional stimulatory effect. To provide evidence that
PGE2 causes an increase in intracellular cAMP, an enzyme
immunoassay was used. Indeed, in PGE2-treated mCCDcl1 cells
cytosolic cAMP concentration was elevated to 137.6 ± 47.2
fmol/µg whole-cell protein compared with 9.5 ± 3.8 fmol/µg
whole-cell protein in matched vehicle-treated control cells
(n = 3).
Figure 3. EP1, EP2, and EP3 receptors are not involved in mediating the stimulatory effect of PGE2 on ENaC. In the left and middle panels, representative
ISC recordings are shown. At the time point indicated by an arrow, cells were exposed to 10 µM AH6809 (EP2 receptor antagonist; left panel, solid line), 100 nM
sulprostone (EP1/EP3 receptor agonist; middle panel, solid line), or vehicle in matched control recordings (control, dashed line). Approximately 30 min later, all
cells were exposed to 100 nM basolateral PGE2 and subsequently to apical amiloride (Ami; 10 µM) as indicated. Summary data (right panel) are presented as
ΔISC values, which were determined by subtracting the corresponding baseline ISC from the ISC reached in the presence (+) or absence (−) of PGE2, AH6809, and
sulprostone as indicated. Data are presented as individual values and their mean ± SEM; paired data are connected by dashed lines. Numbers of experiments
are given in parenthesis. ns, P > 0.05, one-way ANOVA with Tukey’s multiple comparison test.
Figure 4. PGE2 stimulates ENaC activity via basolateral EP4 receptors. (A) The left and middle panel show representative ISC recordings in which vehicle
(control; dashed lines) or EP4 receptor antagonists (100 µM AH23848 or 2 µM GW627368X; solid lines) were added basolaterally at the time point indicated by
an arrow. Approximately 30 min later, all cells were exposed to 100 nM basolateral PGE2 and subsequently to apical amiloride (Ami; 10 µM) as indicated.
Summary data (right panel) are presented as ΔISC values, which were determined by subtracting the corresponding baseline ISC from the ISC reached in the
presence (+) or absence (−) of PGE2, AH23848, and GW627368X as indicated. (B) Representative ISC recordings (left panel) from cells exposed basolaterally to
the EP4 receptor agonist TCS2510 (solid line; 100 nM) or vehicle (control, dashed line) at the time point indicated by the arrow. Apical amiloride (10 µM) was
applied as indicated. Summary data (right panel) are presented as ΔISC values determined by subtracting the corresponding baseline ISC from the ISC reached
after treating cells with TCS2510 (+) or vehicle (−). Data are presented as individual values and their mean ± SEM; paired data are connected by dashed lines.
Numbers of experiments are given in parentheses. ***, P < 0.001, one-way ANOVA with Tukey’s multiple comparison test.
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The stimulatory effect of PGE2 on ENaC activity is preserved in
cells pretreated with aldosterone
As shown previously (Gaeggeler et al., 2005; Mansley et al.,
2018), mCCDcl1 cells treated with a physiological concentration
of aldosterone (3 nM) responded with a sustained increase of ISC
from 8.7 ± 0.9 μA·cm−2 to 17.9 ± 1.6 μA·cm−2 (n = 9, P < 0.001;
Fig. 6) reaching a new plateau within∼2 h. Basolateral application
of PGE2 (100 nM) at the plateau of the aldosterone response
caused a further rapid (within 5–10 min) increase in ISC by 16.8 ±
1.1 μA·cm−2. This stimulatory effect of PGE2 in aldosterone-treated
cells was similar to that in matched vehicle-treated control cells,
averaging 17.3 ± 1.5 μA·cm−2 (n = 11; Fig. 6). These results indicate
that the stimulatory effect of PGE2 on ENaC is independent of
the signaling pathways mediating the stimulatory effect of
aldosterone.
PGE2 is generated and secreted by mCCDcl1 cells exposed to
the precursor arachidonic acid and stimulates ENaC activity in
an autocrine manner
The finding that exogenously applied PGE2 stimulates ENaC
activity in mCCDcl1 cells raised the question whether endoge-
nously generated prostanoids may elicit a similar response. To
promote the synthesis of endogenous PGE2, its precursor ara-
chidonic acid was applied at a concentration of 50 µM. At this
concentration, arachidonic acid is not rate limiting for the bio-
synthesis of PGE2 (Bonvalet et al., 1987). Apical application of
arachidonic acid increased ISC from 9.8 ± 1.5 μA·cm−2 to 25.1 ± 2.4
μA·cm−2 (n = 8, P > 0.001; Fig. 7 A, dashed line). The stimulated
ISC was inhibited by amiloride, which indicates that the stimu-
latory effect of arachidonic acid is due to increased ENaC-
mediated transepithelial sodium transport. The stimulatory
effect of arachidonic acid was similar to that of PGE2, and sub-
sequent application of PGE2 (100 nM) to the basolateral bath did
not increase ISC further (ΔISC = −1.5 ± 0.6 μA·cm−2). Importantly,
treating mCCDcl1 cells with the COX-1/2 inhibitor indomethacin
(50 µM) completely prevented the stimulatory response to ar-
achidonic acid (ΔISC = 0.3 ± 0.2 μA·cm−2, n = 8; Fig. 7 A, solid
line). In contrast, the stimulatory effect of subsequently applied
PGE2 was fully preserved (ΔISC =10.7 ± 1.3 μA·cm−2, n = 8). Thus,
mCCDcl1 cells are capable of synthesizing and releasing a COX-
derived prostanoid, most likely PGE2, which can stimulate ENaC
activity in an autocrine manner, preventing a further stimula-
tion by exogenous PGE2. This hypothesis is further supported by
the finding that the stimulatory effect of arachidonic acid was
largely reduced in the presence of the EP4 receptor antagonists
AH23848 (100 µM) and GW627368X (2 µM) in the basolateral
solution (Fig. 7 B). In mCCDcl1 cells, we did not observe an in-
hibitory effect of arachidonic acid on ENaC-mediated ISC. In
contrast, ENaC inhibition via cytochrome P450 epoxygenase-
dependent pathways has been reported in microdissected rat
CCD (Wei et al., 2004) and mpkCCD cells (Pavlov et al., 2011).
The lack of an inhibitory effect in mCCDcl1 cells cannot be at-
tributed to an insufficient concentration of arachidonic acid
used in our experiments because in rat CCD, the concentration
required to inhibit ENaC activity by 50% was ∼2 µM.
In additional experiments cell culture medium was collected
from the basolateral bath of cells treated with apical arachidonic
acid (donor cells). The collected medium was transferred to the
basolateral compartment of nontreated mCCDcl1 cells (receiver
cells) in a 1:1 (vol/vol) ratio. This resulted in a significant stim-
ulation of ISC in the receiver cells (ΔISC = 5.6 ± 1.4 μA·cm−2, n = 7).
Subsequent application of PGE2 had an additional but less pro-
nounced stimulatory effect on ISC. The stimulatory effect of
medium from donor cells was preserved when COX-1/2 activity
Figure 5. The stimulatory effect of PGE2 is similar and not additive to
those of vasopressin and forskolin. (A–C) Representative traces of con-
tinuous ISC recordings from mCCDcl1 cells are shown in the left panels, and
data from similar experiments are summarized in the corresponding right
panels. (A) At the time point indicated by an arrow, cells were exposed to 25
pM basolateral vasopressin (solid line) or vehicle in matched control re-
cordings (control, dashed line). About 20 min later all cells were exposed to
100 nM basolateral PGE2 and subsequently to apical amiloride (Ami; 10 µM)
as indicated. (B) At the time point indicated by an arrow, cells were exposed
to 100 nM basolateral PGE2 (solid line) or vehicle in matched control re-
cordings (control, dashed line). Approximately 20 min later, all cells were
exposed to 25 pM basolateral vasopressin and subsequently to apical amil-
oride (10 µM) as indicated. (C) At the time point indicated by an arrow, cells
were exposed to 10 µM forskolin (solid line) to stimulate adenylyl cyclase or
to vehicle in matched control recordings (control, dashed line). Approximately
20 min later, all cells were exposed to 100 nM basolateral PGE2 and subse-
quently to apical amiloride (10 µM) as indicated. Summary data (right panel)
are presented as ΔISC values, which were determined by subtracting the
corresponding baseline ISC from the ISC reached in the presence (+) or ab-
sence (−) of PGE2, vasopressin, and forskolin as indicated. Data are presented
as individual values and their mean ± SEM. Paired data are connected by
dashed lines. Numbers of experiments are given in parentheses. *, P < 0.05;
**, P < 0.01; ***, P < 0.001, paired Student’s t test.
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in the receiver cells was inhibited by indomethacin (ΔISC 5.4 ±
1.3 μA·cm−2, n = 7; Fig. 7 C). This rules out the possibility that the
stimulatory effect of the transferred medium was mediated by a
contamination with arachidonic acid. Finally, the stimulatory
effect of the transferred medium on ENaC activity was largely
abolished when the receiver cells were pretreated with the EP4
receptor antagonist GW627368X in the basolateral bath (ΔISC =
of 1.4 ± 0.5 μA·cm−2). In contrast, medium transfer increased ISC
by 12.4 ± 1.3 μA·cm−2 in nontreated matched control cells (n = 4,
P < 0.001; Fig. 7 D).
Stimulation of ENaC in mCCDcl1 cells by arachidonic acid
requires COX-1 activity
Similar to treating mCCDcl1 cells with the nonselective COX-1/
2 inhibitor indomethacin (Fig. 7 A), treating cells with the se-
lective COX-1 inhibitor SC-560 (0.14 µM; Fig. 8 A) largely pre-
vented the stimulatory effect of arachidonic acid on ENaC
activity. The arachidonic acid–induced ΔISC was reduced to 4.4 ±
0.6 μA·cm2 (n = 6) compared with the effect of arachidonic acid in
matched controls with a ΔISC of 17.1 ± 2.7 μA·cm2 (n = 7, P < 0.05).
In contrast, lumiracoxib (2 µM; Fig. 8 B), a highly selective COX-
2 inhibitor, did not prevent the stimulatory effect of arachidonic
acid. Indeed, in cells treated with lumiracoxib, the effect of ara-
chidonic acid was preserved with a ΔISC of 15.7 ± 2.7 μA·cm−2 (n =
6), whichwas not different from the ΔISC of 18.9 ± 2.7 μA·cm−2 (n =
6) elicited by arachidonic acid in vehicle-treated control cells.
These data indicate that COX-1 is the dominant isoenzyme in-
volved in PGE2 generation in mCCDcl1 cells. To confirm synthesis
and basolateral secretion of PGE2, its concentration was measured
in the basolateral culture medium of mCCDcl1 cells. The concen-
tration of PGE2 in the basolateral medium ofmCCDcl1 cells exposed
to apical arachidonic acid was significantly higher (16.3 ± 3.8
nmol·l−1, n = 6) than that of vehicle-treated control cells (0.3 ± 0.2
nmol·l−1, n = 8, P < 0.01; Fig. 8 C). The arachidonic acid–dependent
increase in basolateral PGE2 concentration was abolished by the
COX-1 inhibitor SC-560 (0.3 ± 0.1 nmol·l−1, n = 7, P < 0.001), but
not by the COX-2 inhibitor lumiracoxib (7.4 ± 5.4 nmol·l−1, n = 7,
P > 0.05), which is consistent with the ISC data reported above.
Transcripts for EP receptors and for enzymes of the PGE2
biosynthetic pathway were detected in mCCDcl1 cells
RT-PCR experiments revealed the presence of transcripts for EP4
and EP1 receptors in mCCDcl1 cells. In contrast, transcripts for
EP2 or EP3 receptors were not detected (Fig. 9 A). Moreover,
transcripts for several enzymes (COX-1, COX-2, mPGES2, and
cPGES) involved in the biochemical pathway of PGE2 synthesis
were detected not including mPGES1 (Fig. 9 B). Targets were
confirmed by extracting and sequencing the PCR bands of
interest.
Discussion
The present study provides evidence that basolateral, but not
apical application of PGE2 stimulates ENaC-dependent trans-
epithelial sodium transport in mCCDcl1 cells. Moreover, it dem-
onstrates that this stimulatory effect is mediated by EP4 receptor
signaling and is due to increased ENaC activity resulting, at least
in part, from enhanced channel expression at the apical cell
surface. Finally, experiments with the PGE2 precursor arachi-
donic acid indicate that mCCDcl1 cells can synthesize and release
PGE2 to stimulate transepithelial sodium transport in an auto-
crine manner.
The sustained stimulatory effect of PGE2 on ENaC-mediated
ISC in mCCDcl1 cells is reminiscent of similar effects previously
observed in Xenopus laevis A6 (Kokko et al., 1997; Matsumoto
et al., 1997) and canine MDCK renal epithelial cells (Wegmann
and Nüsing, 2003). This challenges the view that PGE2 mainly
inhibits sodium absorption in the collecting duct. Interestingly,
an inhibitory effect of PGE2 on sodium absorption was not ob-
served in isolated perfused rat CCD (Chen et al., 1991). Moreover,
the inhibitory effects of PGE2 on Na+ transport inmicrodissected
rabbit tubules (Stokes and Kokko, 1977; Iino and Imai, 1978) and
primary cultures of rabbit principal CCD cells (Ling et al., 1992)
were short-term, occurring within a few minutes of basolateral
PGE2 application. In contrast, the stimulatory effect observed in
mCCDcl1 cells in the present study reached a maximum within
∼10 min and was sustained. In this context, it is of interest that a
biphasic action of PGE2 has been reported in Xenopus A6 renal
epithelial cells with an acute inhibition (3–6 min) and a delayed
stimulation (10–50 min) of ENaC by basolateral PGE2 (Kokko
et al., 1994, 1997; Worrell et al., 2001). The acute inhibition is
probably caused by an increase in intracellular Ca2+ signaling. In
contrast, the delayed stimulatory effect is due to an increase in
intracellular cAMP leading to an increase in the number of
channels expressed in the apical membrane (Kokko et al., 1994).
Figure 6. The stimulatory effect of PGE2 upon ENaC activity
is preserved in cells pretreated with aldosterone. The left
panel shows representative ISC recordings in which vehicle
(control; dashed line) or aldosterone (3 nM; solid line) were
added bilaterally at the time point indicated by an arrow. Ap-
proximately 2 h later, cells were exposed to 100 nM basolateral
PGE2 and subsequently to apical amiloride (Ami; 10 µM) as in-
dicated. Summary data (right panel) are presented as ΔISC val-
ues, which were determined by subtracting the corresponding
baseline ISC from the ISC reached in the presence (+) or absence
(−) of aldosterone and PGE2 as indicated. Data are presented as
individual values and their mean ± SEM. Paired data are con-
nected by dashed lines. Numbers of experiments are given in
parentheses. ***, P < 0.001, paired Student’s t test.
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This latter interpretation is in good agreement with our obser-
vation in mCCDcl1 cells.
In a previous study, our group reported that PGE2 stimulates
Cl− secretion in murine M-1 CCD cells (Sandrasagra et al., 2004).
In this latter study, no stimulatory effect of PGE2 on the
amiloride-sensitive ISC component was observed. A possible
explanation for this discrepancy is that in M-1 cells, ENaC-
dependent ISC is usually maximally stimulated under baseline
conditions, which makes it difficult to detect any additional
stimulatory effects on ENaC. A prestimulation of ENaC by de-
oxycorticosterone acetate in the majority of experiments may be
a reason why no stimulatory effect of 10–100 nM PGE2 was
detected in isolated rabbit collecting tubules (Stokes and Kokko,
1977; Iino and Imai, 1978). Moreover, in our previous study
(Sandrasagra et al., 2004), we focused on the short-term effects
of PGE2 and may have overlooked a delayed stimulatory re-
sponse. In mCCDcl1 cells the sustained ISC increase in response to
PGE2 is clearly due to a stimulatory effect on ENaC. This is
evidenced by the finding that the response could not be elicited
in the presence of amiloride and that the PGE2-stimulated ISC
was completely inhibited by amiloride. In contrast, a minor
rapid and transient ISC peak preceding the sustained stimulatory
response to PGE2 was preserved in the presence of amiloride or
in the presence of the EP4 receptor antagonist GW627368X. This
suggests that the transient peak response is not mediated by EP4
and reflects electrogenic Cl− secretion reminiscent of the Cl−
secretory response observed in M-1 cells (Sandrasagra et al.,
2004). Thus, under certain conditions, mCCDcl1 cells, like M-1
cells and mouse inner medullary collecting duct cells (Rajagopal
et al., 2014), may have the ability to secrete Cl− in response to
Figure 7. Stimulation of ENaC activity in
mCCDcl1 cells by arachidonic acid is mediated
via basolateral EP4 receptors and constitu-
tively active COX. The left panel in A and the
left and middle panels in B show representative
traces of continuous ISC recordings. 50 µM in-
domethacin (A) or 100 µM AH23848 or 2 µM
GW627368X (B; solid lines) was added basolat-
erally at the time point indicated by an arrow.
Dashed lines indicate matched control record-
ings treated with the respective vehicle (con-
trol). About 30 min later cells were exposed to
50 µM apical arachidonic acid and in A followed
by basolateral 100 nM PGE2. Finally, apical 10 µM
amiloride was added as indicated. Summary data
(right panel) are presented as ΔISC values, which
were determined by subtracting the corresponding
baseline ISC from the ISC reached in the presence (+)
or absence (−) of indomethacin, arachidonic acid,
PGE2, AH23848, and GW627368X as indicated. The
left panels in C and D show representative traces
of continuous ISC recordings in which vehicle
(control; dashed lines), 50 µM indomethacin, or
2 µM GW627368X (solid lines) was added baso-
laterally at the time point indicated by an arrow.
Approximately 30 min later, medium from the
basolateral compartment of a second set of cells
(donor cells; not depicted) whichwere treatedwith
apical 50 µM arachidonic acid was transferred to
the basolateral compartment (indicated as medium
transfer) in a 1:1 (vol/vol) ratio. This was followed
in C by basolateral 100 nM PGE2. Finally, as indi-
cated, 10 µM amiloride was applied to all cells.
Summary data (right panel) are presented as ΔISC
values, which were determined by subtracting the
corresponding baseline ISC from the ISC reached in
the presence (+) or absence (−) of indomethacin,
GW627368X, PGE2, and medium transfer as indi-
cated. Summary data are presented as individual
values and their mean ± SEM. Paired data are
connected by dashed lines. Numbers of experi-
ments are given in parentheses. ***, P < 0.001; **,
P < 0.01; *, P < 0.05, one-way ANOVAwith Tukey’s
multiple comparison test or unpaired Student’s
t test, where appropriate.
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PGE2. However, in mCCDcl1 cells, the predominant effect of PGE2
is a substantial and sustained stimulation of ENaC-dependent
Na+ absorption. Importantly, the estimated EC50 of ∼7.1 nM
for this stimulatory PGE2 effect is within a range that may be
relevant in vivo (Bonvalet et al., 1987).
The present study provides pharmacological evidence that
the stimulatory effect of PGE2 on ENaC is mediated by EP4 re-
ceptors in the basolateral membrane of mCCDcl1 cells. This
conclusion is further supported by the finding that PGE2 caused
an increase in intracellular cAMP as expected for a Gαs-coupled
receptor. In agreement with the functional data, transcripts for
EP4 receptor were detected in mCCDcl1 cells consistent with
previous reports of EP4 receptor expression in the collecting
duct (Jensen et al., 2001; Hao and Breyer, 2008). In contrast,
transcripts for EP2 or EP3 receptors were not detected inmCCDcl1
cells. The absence of EP2 receptor transcripts is plausible, be-
cause renal EP2 receptor expression is thought to be limited to
interstitial cells and the vasculature (Li et al., 2017). The lack of
EP3 receptor expression in mCCDcl1 cells was unexpected and
may not reflect the situation in the native collecting duct, where
EP3 receptor is expressed, but its cellular localization and precise
physiological role is less clear (Hao and Breyer, 2008). Of in-
terest is the detection of EP1 receptor transcripts in mCCDcl1 cells
consistent with the reported expression of EP1 receptor in the
collecting duct (Guan et al., 1998) and M-1 cells (Sandrasagra
et al., 2004). EP1 receptor is a Gαq/11-coupled receptor, and its
activation leads to a rise in cytosolic Ca2+ via the IP3/diacyl-
glycerol pathway (Narumiya et al., 1999; Breyer and Breyer,
2000b). An EP1-mediated increase in intracellular calcium is
thought to be the mechanism by which PGE2 inhibits sodium
absorption in rabbit and mouse CCD (He´bert et al., 1991; Guan
et al., 1998; Nasrallah et al., 2018). Thus, whether PGE2 inhibits
or stimulates sodium absorption in the collecting duct may de-
pend on the relative expression of EP1 versus EP4 receptors
which may vary in different parts of the collecting duct according
to physiological needs. It has been speculated that in M-1 cells the
initial Cl− secretory response to PGE2 is mediated through EP1
receptor activation and subsequent stimulation of Ca2+-activated
chloride channels (Sandrasagra et al., 2004). This may also be the
mechanism underlying the small ENaC-independent transient ISC
response to PGE2 occasionally observed in mCCDcl1 cells. Pres-
ently, it is unclear whether Cl− secretion is physiologically rele-
vant in CCD cells or becomes relevant under pathophysiological
conditions like in polycystic kidney disease, where it is thought to
contribute to cyst enlargement (Liu et al., 2012; Blanco and
Wallace, 2013). In contrast, it is well established that ENaC func-
tion in the CCD and its appropriate regulation play a key role in
maintaining sodium homeostasis. Thus, the reported stimulatory
effect of PGE2 on ENaC-mediated transepithelial sodium transport
is potentially important under certain physiological and patho-
physiological conditions.
PGE2 is the most abundant prostanoid detected in the kidney,
but the physiologically relevant sites for the synthesis of PGE2
remain to be defined (Hao and Breyer, 2008). The present study
provides evidence that mCCDcl1 cells can synthesize and secrete
PGE2. Indeed, apical exposure to the PGE2 precursor arachidonic
acid caused substantial secretion of PGE2, which reached a
concentration of ∼16 nM in the basolateral culture medium of
treated cells compared with ∼0.3 nM in the basolateral medium
of control cells. From the PGE2 concentration reached in the
basolateral medium of treated cells it can be estimated that
confluent mCCDcl1 cells, covering one tissue culture insert, se-
crete ∼4 µg PGE2 over a 30-min period. This corresponds to a
secretion rate of ∼79 fg PGE2/ng cellular protein per 30min. It is
conceivable that this secretion rate may be achieved in vivo,
Figure 8. Stimulation of ENaC in mCCDcl1 cells by arachidonic acid re-
quires COX-1 activity. (A and B) Representative traces of continuous ISC
recordings from mCCDcl1 cells are shown in the left panels, and data from
similar experiments are summarized in the corresponding right panels. At the
time point indicated by an arrow, cells were exposed to 0.14 µM SC560 (COX-
1 selective inhibitor, solid line) or vehicle in matched control recordings (A;
control, dashed line) or 2 µM lumiracoxib (COX-2 selective inhibitor, solid
line) or vehicle in matched control recordings (B; control, dashed line). Ap-
proximately 30 min later, all cells were exposed to 50 µM apical arachidonic
acid and subsequently to apical amiloride (Ami; 10 µM) as indicated. Summary
data (right panel) are presented as ΔISC values, which were determined by
subtracting the corresponding baseline ISC from the ISC reached in the pres-
ence (+) or absence (−) of SC560, lumiracoxib, and arachidonic acid as indi-
cated. (C) Concentration of PGE2 measured in basolateral cell culture medium
collected from cells in the presence (+) or absence (−) of 50 µM arachidonic
acid, 0.14 µM SC560 and 2 µM lumiracoxib as indicated. The solid arrowhead
indicates the EC50 value for the ISC response upon PGE2 as determined in
Fig. 1. Data are presented as individual values and their mean ± SEM. Numbers
of experiments are given in parentheses. ***, P < 0.001; **, P < 0.01; *, P <
0.05; ns, P ≥ 0.05, one-way ANOVA with Dunn’s multiple comparison test.
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because synthesis rates ranging from ∼800 to >8,000 fg·ng
protein−1·30 min−1 have been reported for PGE2 synthesis in the
collecting duct (Bonvalet et al., 1987; Liu et al., 2014). In light of
the EC50 value of ∼7.1 nM, the concentration of PGE2 of ∼16 nM
explains the robust stimulatory effect observed in medium
transfer experiments when receiver cells were exposed to a 1:1
dilution of the basolateral medium from donor cells. It also ex-
plains why the stimulatory effect was submaximal and why
subsequent exposure to 100 nM PGE2 further stimulated ISC in
these experiments (Fig. 7 C). In contrast, in mCCDcl1 cells ex-
posed to arachidonic acid on the apical side subsequent exposure
to 100 nM PGE2 on the basolateral side had no additional stim-
ulatory effect (Fig. 7 A). This is plausible, because the local PGE2
concentration reached within the vicinity of the basolateral
membrane of mCCDcl1 cells exposed to apical arachidonic acid is
probably much higher than the ∼16 nM measured in the bulk
medium. Thus, autocrine secretion of PGE2 may well be suffi-
cient to achieve a maximal EP4 receptor-mediated stimulatory
effect on the amiloride-sensitive ISC (Fig. 7).
In the renal cortex, COX-1 and downstream prostaglandin
synthases are constitutively expressed, while basal expression of
COX-2 is low (Yang et al., 1998; Murakami et al., 2002; Tanikawa
et al., 2002; Hao and Breyer, 2008). This study provides evi-
dence that transcripts for COX-1, mPGES2, and cPGES, but not
mPGES1, are expressed inmCCDcl1 cells. Once arachidonic acid is
processed by COX-1, the biosynthesis of PGE2 can be achieved by
mPGES2 or cPGES. The stimulatory effect of arachidonic acid on
ENaC-dependent ISC was abolished in mCCDcl1 cells treated with
the nonselective COX-1/2 inhibitor indomethacin or the selec-
tive COX-1 inhibitor SC560. In contrast, the selective COX-2 in-
hibitor lumiracoxib did not prevent the stimulatory effect of
arachidonic acid. These findings indicate that COX-1 plays a
major role in PGE2 synthesis inmCCDcl1 cells, which is consistent
with the finding that COX-1 is the primary isoform in native CCD
(Vitzthum et al., 2002) with a preferential localization in CCD
principal cells (Caˆmpean et al., 2003).
cPGES transcripts are ubiquitously expressed in mouse epi-
thelial cells of the connecting tubule and collecting duct (Chen
et al., 2017; Ransick et al., 2019), and immunoreactive cPGES has
been detected in cultured mouse inner medullary collecting duct
cells (Zhang et al., 2003). Therefore, its detection in mCCDcl1
cells is not surprising. Interestingly, mPGES2 is thought to be
primarily expressed in intercalated cells (Yang et al., 2006a),
whereas mPGES1 has been detected in principal cells (Chen
et al., 2017; Wang et al., 2018; Ransick et al., 2019). The
mCCDcl1 cell line used in this study is a clonal cell line derived
from microdissected mouse CCD and retains features typical for
CCD principal cells (Gaeggeler et al., 2005, 2011; Gonzalez-
Rodriguez et al., 2007; Mansley et al., 2015, 2018, 2019). Thus,
at first sight it may appear surprising that transcripts for
mPGES2 but not for mPGES1 were detected in mCCDcl1 cells.
However, mPGES1 expression is induced by cytokines and in-
flammatory stimuli (Murakami et al., 2002; Hao and Breyer,
2008). Therefore, basal expression of mPGES1 in CCD princi-
pal cells is probably low and may have been below the detection
limit in mCCDcl1 cells. Low basal expression of mPGES1 is also
consistent with the finding that single-cell transcriptome
analysis of major renal collecting duct cells types in mouse re-
vealed a weaker expression of mPGES1 in CCD principal cells
compared with cPGES (Chen et al., 2017). Interestingly, it has
been reported that mCCDcl1 cells show some plasticity consistent
with the ability to transition between principal and intercalated
cells (Assmus et al., 2018). There is little doubt that the ENaC-
dependent ISC observed in the present study is generated by
mCCDcl1 cells that predominantly behave like principal cells.
However, at present it is unclear whether PGE2 synthesis and
Figure 9. Transcripts for EP receptors and for enzymes of the PGE2 biosynthetic pathway were detected in mCCDcl1 cells. Specific primers were used
to detect the transcript expression of the prostanoid receptors EP1–EP4 (A), as well as key enzymes involved in PGE2 synthesis, namely COX-1, COX-2, mPGES1,
mPGES2, and cPGES (B). Transcript expression was determined in RNA extracted from mCCDcl1 cells, as well as from mouse cortical kidney and lung ho-
mogenates. H2O and primers recognizing β-actin served as no-template and loading control, respectively. Expected individual transcript sizes are indicated by
open arrowheads.
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secretion occurs in the same cells responsible for the amiloride-
sensitive ISC or whether this occurs in distinct interspersed cells
with an intercalated phenotype that may be present in the
mCCDcl1 monolayer. It is tempting to speculate that the latter
scenario may provide a mechanism by which intercalated cells
can regulate principal cell ion transport function in a paracrine
manner. Whether this occurs in native tissue and is physiolog-
ically relevant remains to be determined.
The biotinylation experiments performed in this study in-
dicate that PGE2 stimulates ENaC activity at least in part by
increasing the abundance of ENaC at the apical plasma mem-
brane. This is consistent with the finding that PGE2 via EP4 re-
ceptor increases cytosolic cAMP in mCCDcl1 cells, as increased
surface abundance of ENaC has previously been observed in
response to an elevated cytosolic cAMP concentration (Snyder,
2000; Butterworth et al., 2005). Indeed, it is well known that
vasopressin can stimulate ENaC-mediated sodium transport
(Schafer and Troutman, 1990; Ecelbarger et al., 2000; Ecelbarger
et al., 2001; Nicco et al., 2001) via the Gαs-coupled V2-receptor
and subsequent activation of the AC/cAMP/PKA pathway
(Schafer and Hawk, 1992; Loffing and Korbmacher, 2009; Roos
et al., 2013). This involves an increased abundance of the β- and
γ-ENaC subunits at the apical plasmamembrane, possibly due to
the insertion of ENaC-containing vesicles into the plasma
membrane from a subapical pool (Snyder, 2000; Butterworth
et al., 2005, 2012). Additional mechanisms probably contribute
to stimulate ENaC activity following the activation of the AC/
cAMP/PKA pathway (e.g., phosphorylation events; Yang et al.,
2006b) and an increase in channel open probability (Bugaj et al.,
2009). Thus, the stimulatory effect of PGE2 on ENaC, like that of
vasopressin, is probably more complex than simply increasing
channel surface expression (Kortenoeven et al., 2015).
The conclusion that the PGE2 effect on ENaC is mediated by
an activation of the AC/cAMP/PKA pathway is further sup-
ported by the observation that the effects of PGE2 and vaso-
pressin were nonadditive in mCCDcl1 cells. This indicates that
the signaling pathways of PGE2 and vasopressin converge. Im-
portantly, the stimulatory effect of PGE2 on ENaC activity was
preserved when mCCDcl1 cells were prestimulated with aldos-
terone. In contrast to the rapid effects of PGE2 and vasopressin,
the stimulatory effect of aldosterone was much slower. This
slower time course of the aldosterone response is consistent
with observations in isolated perfused rat CCD (Reif et al., 1986).
It is not surprising, because the response to aldosterone is me-
diated by the mineralocorticoid receptor and involves highly
complex regulatory mechanisms that are not yet fully under-
stood but include transcriptional regulation of the channel and
of regulatory proteins (Loffing and Korbmacher, 2009; Rossier,
2014).
It has been postulated that the well-documented synergistic
stimulation of sodium transport by vasopressin and aldosterone
(Tomita et al., 1985; Reif et al., 1986; Chen et al., 1990, 1991;
Schafer and Hawk, 1992; Snyder et al., 2004; Bugaj et al., 2009)
is important to achieve maximal sodium reabsorption and urine
concentration due to the simultaneous stimulation of water
permeability by vasopressin (Reif et al., 1986). At present, the
role of PGE2 in regulating sodium and water transport in the
distal nephron and collecting duct is less clear. It is commonly
thought that prostanoids synthesized along the renal tubular
system cause natriuresis by reducing medullary sodium and
water reabsorption. This may be particularly relevant under
conditions of elevated salt intake (Hao and Breyer, 2007) or
when tubular fluid flow is high (Flores et al., 2012). Inhibition of
sodium and water reabsorption by prostanoids may be due to
various mechanisms such as their ability to blunt the action of
vasopressin, promote medullary blood flow, and directly inhibit
sodium transport in the distal nephron by reducing the activity
of the Na+/K+-ATPase or ENaC (Stokes and Kokko, 1977; He´bert
et al., 1990; Zeidel, 1993; Guan et al., 1998; Hao and Breyer, 2007;
Flores et al., 2012). On the other hand, PGE2 increased water flux
and elevated sodium absorption in primary cultures of freshly
isolated tubules (Canessa and Schafer, 1992; Wang et al., 2016).
Interestingly, the expression pattern of enzymes and receptors
associated with prostanoid signaling may be altered under
conditions of low salt intake or volume contraction (Hao and
Breyer, 2008; Li et al., 2017; Wang et al., 2018). For example,
in rabbits, salt restriction markedly stimulated PGE2 biosyn-
thesis in the outer medulla and cortex (Davila et al., 1978; Stahl
et al., 1979). This may indicate that PGE2 is needed to minimize
renal sodium excretion. Thus, there is evidence that the effect of
PGE2 on transepithelial sodium and water flux depends on the
physiological or pathophysiologic setting. A different respon-
siveness to prostanoids may also explain why indomethacin
decreased blood pressure in animals on a low-sodium diet but
increased blood pressure in sodium-repleted rats (Stahl et al.,
1981).
In conclusion, our results demonstrate that PGE2 can stimu-
late ENaC in mCCDcl1 cells, which depends on EP4 receptor ac-
tivation and a rise in cytosolic cAMP. Furthermore, these cells
can synthesize and secrete PGE2, which acts in an autocrine/
paracrine manner to stimulate ENaC-mediated sodium trans-
port. The (patho-)physiological implications of these findings
remain to be elucidated. However, the findings suggest that
under certain conditions, locally generated PGE2 may stimulate
sodium absorption in the ASDN. Conversely, it is conceivable
that pharmacological inhibition of PGE2 synthesis may attenuate
sodium reabsorption in the ASDN in states with increased local
production of PGE2. Additional studies are needed in native
tissue and genetically modified animal models to explore a
possible dual regulatory role of PGE2 associated with its ability to
inhibit or stimulate sodium absorption in collecting duct cells.
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